INGHAM Institute researchers have made yet another big discovery and aren’t slowing down.
The correlative microscopy group has found a cell-analysis method that combines nanotechnology with pathology.
It could improve understanding of chronic inflammatory processes in cancer.
The study was recently published in the Journal of Histochemistry and Cytochemistry.
It found the method could provide a more accurate view of cancer-cell structure.
Chief investigator Murray Killingsworth said applying nanoparticles as cellular probes gave them a super-resolution view of the cells.
‘‘This novel approach enables us to identify cells, visualise their interactions and identify changes with more certainty than traditional cell-analysis methods,’’ Dr Killingsworth said.
‘‘This finding can be translated into applications across a range of critical disease areas we are working on, in particular chronic inflammatory processes in cancer, renal fibrosis and macular degeneration of the retina.
‘‘We hope it will help us to get a more detailed view of the complex cell changes that define the production of disease, and look for the causes of these diseases and how they can be treated.’’